Psychoneuroendocrinology
Volume 33, Issue 8 , Pages 1124-1131, September 2008

Progesterone reduces wakefulness in sleep EEG and has no effect on cognition in healthy postmenopausal women

  • P. Schüssler

      Affiliations

    • Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, D-80804 Munich, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 89 30622 347; fax: +49 89 30622 552.
  • ,
  • M. Kluge

      Affiliations

    • Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, D-80804 Munich, Germany
  • ,
  • A. Yassouridis

      Affiliations

    • Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, D-80804 Munich, Germany
  • ,
  • M. Dresler

      Affiliations

    • Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, D-80804 Munich, Germany
  • ,
  • K. Held

      Affiliations

    • Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, D-80804 Munich, Germany
  • ,
  • J. Zihl

      Affiliations

    • Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, D-80804 Munich, Germany
    • Ludwig Maximilians University, Department of Psychology, Neuropsychology, Munich, Germany
  • ,
  • A. Steiger

      Affiliations

    • Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, D-80804 Munich, Germany

Received 21 January 2008; received in revised form 17 May 2008; accepted 23 May 2008.

Summary 

Sleep is frequently impaired in postmenopausal women. Progesterone prompted benzodiazepine-like effects on sleep EEG in young normal male subjects. Aim of this study was to test if treatment with progesterone improves sleep after menopause.

A randomised double blind crossover design study with 2 treatment intervals of 21 days duration separated by a 2 weeks washout was performed. An oral dose of 300mg micronized progesterone was given each for 21 days. At the beginning and the end of the two intervals a sleep EEG was recorded and cognitive performance was assessed in 10 healthy postmenopausal women (age: 54–70 years).

Progesterone treatment led to a decrease of intermittent time spent awake. During the first third of the night rapid eye movement (REM) sleep increased. The spectral analysis of the EEG resulted in no significant differences of the power spectra. Progesterone did not affect cognitive performance.

In summary progesterone demonstrated a distinct sleep promoting effect by reduction of time of wake without impairing cognitive functions during daytime.

As possible mechanisms of progesterone a GABA-agonistic effect and the regulation of gene expression via the progesterone receptor are discussed. Progesterone might be useful in the treatment of sleep disturbances of postmenopausal women.

Keywords: Progesterone, Sleep, Postmenopause, Cognition

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0306-4530(08)00137-6

doi:10.1016/j.psyneuen.2008.05.013

Psychoneuroendocrinology
Volume 33, Issue 8 , Pages 1124-1131, September 2008